Loading...
Low dose liraglutide in Indian patients with type 2 diabetes in the real world setting
Liraglutide, a human glucagon-like peptide-1 receptor agonist, decreases glycosylated hemoglobin and causes weight loss. However, the cost of therapy and gastrointestinal side- effects such as nausea and diarrhea are important impediments to adherence and long-term compliance. We assessed the effica...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3830340/ https://ncbi.nlm.nih.gov/pubmed/24251194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.119629 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|